- United States
- /
- Semiconductors
- /
- NasdaqGS:ACLS
Axcelis Technologies (ACLS) Valuation Check After Mixed Short And Long Term Share Price Performance
Axcelis Technologies stock: recent performance snapshot
Axcelis Technologies (ACLS) has drawn attention after its recent trading performance, with the shares last closing at US$86.62 and showing mixed returns over the month, the past 3 months, and the past year.
See our latest analysis for Axcelis Technologies.
Recent momentum has been mixed, with a 7 day share price return of 3.6% and a 30 day share price return of 2.7%, set against a 90 day share price return decline of 4.6% and a 1 year total shareholder return of 47.1%. Short term strength therefore contrasts with a stronger longer term record.
If Axcelis has you thinking about where else growth stories could emerge in chips and computing, it may be a good moment to scan 35 AI infrastructure stocks for fresh ideas.
So with Axcelis shares trading around US$86.62, modest revenue growth, lower recent net income and a small gap to analyst targets, is the market already factoring in the future, or is there still a buying opportunity?
Most Popular Narrative: 5.8% Undervalued
Axcelis Technologies' most followed narrative pegs fair value at $92, a touch above the last close of $86.62, and builds that view on specific revenue, margin and valuation assumptions.
Emerging requirements for higher voltage and advanced power management in AI data centers, 5G/6G, and renewable energy are enlarging the addressable market for precise ion implantation, creating additional long-term growth tailwinds for Axcelis's core offerings that could drive sustained revenue growth.
Want to see what kind of revenue path, margin reset and future P/E multiple need to line up to support that $92 figure? The narrative spells out a detailed earnings and cash flow roadmap, along with assumptions about how the market might price Axcelis a few years from now, and leaves plenty of room for you to test those numbers against your own view.
Result: Fair Value of $92 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, heavy China exposure and softer demand in some mature and memory segments could quickly challenge the idea that Axcelis is trading below fair value.
Find out about the key risks to this Axcelis Technologies narrative.
Another angle on value: DCF sends a different signal
That 5.8% undervaluation story sits uncomfortably next to our DCF model, which puts Axcelis' fair value at about $35.02 per share, far below the current $86.62. If the cash flow path looks this tight, is the multiple-based fair value leaning too much on sentiment rather than cash generation?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Axcelis Technologies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 47 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
If the mixed signals here leave you slightly on the fence, it is worth looking through the numbers yourself and forming a clear view, especially since our work highlights both risks and potential rewards that the market is weighing through 1 key reward and 2 important warning signs.
Ready to hunt for your next idea?
If Axcelis has sharpened your focus, do not stop here. Use the Simply Wall Street Screener to line up fresh ideas before the market moves without you.
- Target quality at a discount by scanning our list of 47 high quality undervalued stocks that combine solid fundamentals with prices the market may be underappreciating.
- Prioritize resilience by checking out 77 resilient stocks with low risk scores, a group of companies with lower risk scores that may suit a steadier approach to building wealth.
- Spot tomorrow's potential standouts early with our screener containing 24 high quality undiscovered gems, highlighting lesser known names backed by strong underlying numbers.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:ACLS
Axcelis Technologies
Designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific.
Flawless balance sheet and slightly overvalued.
Similar Companies
Market Insights
Weekly Picks

From a “Shark Tank” Snub to an Air Force “Yes”: Why Virtuix at $3.50 May Be the Market’s Most Mispriced AI Story

The Best-Funded Quantum Platform and Still a Stock Priced for Perfection

The Wafer Giant Threatening NVIDIA's GPU Hegemony
Netflix’s Business Quality Is Clear. The Harder Question Is Whether The Stock Is Still Cheap
Recently Updated Narratives

Improving NOI growth visibility on wider rent gap

Nike - A Fundamental and Historical Valuation

ANAB has a scaling and rising royalty stream, one up and coming new royalty, a loan that dies in 2027 which will result in a doubling
Popular Narratives

Mastercard: The Best Dividend Stock You're Ignoring

Adobe: A Probabilistic Case for Undervaluation

